Reversal of long-term dendritic spine alterations in Alzheimer disease models
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Synapse loss is strongly correlated with cognitive impairment in Alzheimer's disease (AD). We have previously reported the loss of dendritic spines and the presence of dystrophic neurites in both the hippocampi of transgenic mice overexpressing amyloid precursor protein (APP) and in the human brain affected with AD. In the studies reported here we have asked whether the acute alterations in dendritic spines induced by Aβ, as well as the chronic loss of spine density seen in hAPP transgenic mice, are reversible by treatments that restore the cAMP/PKA/CREB signaling pathway or proteasome function to control levels. The results show that both rolipram and TAT-HA-Uch-L1 restore spine density to near control conditions, even in elderly mice. The results suggest that changes in dendritic structure and function that occur after Aβ elevation are reversible even after long periods of time, and that one could envision therapeutic approaches to AD based on this restoration that could work independently of therapies aimed at lowering Aβ levels in the brain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, at least some evidence suggests structural and functional alterations may be reversible pharmacologically, opening new therapeutic directions in Alzheimer’s disease98.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [98]
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 3×
“Terry RD, et al. (1991) Physical basis of cognitive alterations in Alzheimer’s disease: Synapse loss is the major correlate of cognitive impairment.”
BackgroundCorrelative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · cited 2×
“Double transgenic APP/PS1 mice were obtained by crossing hemizygous transgenic mice (HuAPP695SWE; line tg2576) expressing mutant human APP K670N, M671L (35) with hemizygous PS1 mice that express mutant human PS1M146V (line 6.2) (36).”
BackgroundInfluentialPathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052 · cited 2×
“The changes confirm our earlier studies showing similar changes in both J20 single transgenic and APP/PS1 double transgenic animals and in human AD brain (1).”
BackgroundResultAlzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 1×
“The development of A plaques has been successfully achieved in transgenic mice overexpressing mutated forms of APP (4) and is greatly accelerated in transgenic models overexpressing mutated forms of both APP and PS1 (5).”
BackgroundWolfe, M. S., Xia, W., Ostaszewski, B. L., Diehl, T. S., Kimberly, W. T., & Selkoe, D. J. (1999) · Nature · doi:10.1038/19077 · Cited by 1,916
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Matsuzaki, M., Ellis-Davies, G. C. R., Nemoto, T., Miyashita, Y., Iino, M., & Kasai, H. (2001) · Nature Neuroscience · doi:10.1038/nn736 · Cited by 1,802
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · cited 1×
“Dendritic spine loss is also seen in the brains of PDAPP, Tg2576, and J20 APP transgenic mice (27, 28) and in hippocampal slices treated with A (29, 30).”
BackgroundIncreased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Perez-tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,465
Cited by
Dendritic spine pathology in neuropsychiatric disorders
Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J.-E., & Woolfrey, K. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2741 · Cited by 1,523
Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Park, S.-J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.017 · Cited by 1,349
Hoover, B. R., Reed, M. N., Su, J., Penrod, R. D., Kotilinek, L. A., Grant, M. K., Pitstick, R., Carlson, G. A., Lanier, L. M., Yuan, L.-L., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.030 · Cited by 1,118
“Our growing appreciation for the effects of other dementia-related proteins on dendritic spines (Davies et al., 1987; Selkoe, 2002; Hsieh et al., 2006; Kramer and Schulz-Schaeffer, 2007; Fuhrmann et al., 2007; Knobloch and Mansuy, 2008; Smith et al., 2009) highlights the importance of dendritic spines as a locus in wh…”
BackgroundResultInfluentialExtrasynaptic NMDA Receptor Involvement in Central Nervous System Disorders
Parsons, M. P., & Raymond, L. A. (2014) · Neuron · doi:10.1016/j.neuron.2014.03.030 · Cited by 553
“When applied to cultured cortical neurons, Ab enhances NMDAR endocytosis and decreases synaptic expression (Snyder et al., 2005), consistent with the finding that calcium influx through NMDARs after glutamate uncaging at single spines is significantly reduced after Ab treatment (Shankar et al.”
InfluentialThe role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease
Amidfar, M., de Oliveira, J., Kucharska, E., Budni, J., & Kim, Y.-K. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118020 · Cited by 410
Babiloni, C., Lizio, R., Marzano, N., Capotosto, P., Soricelli, A., Triggiani, A. I., Cordone, S., Gesualdo, L., & Del Percio, C. (2016) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2015.02.008 · Cited by 359
“1 Hz) fluctuations of the blood oxygenation signal (BOLD) in healthy subjects, showing that these fluctuations are temporally correlated across large-scale distributed networks (Biswal et al., 1996; Raichle and Mintun, 2006; Fox and Raichle, 2007; Raichle and Snyder, 2007; Smith et al., 2009; Deco and Corbetta, 2010).”
BackgroundOligomeric Intermediates in Amyloid Formation: Structure Determination and Mechanisms of Toxicity
Fändrich, M. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.01.006 · Cited by 340
Synaptic changes in Alzheimer’s disease and its models
Pozueta, J., Lefort, R., & Shelanski, M. L. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.050 · Cited by 307
Self-citationThe role of CREB signaling in Alzheimer’s disease and other cognitive disorders
Saura, C. A., & Valero, J. (2011) · revneuro · doi:10.1515/rns.2011.018 · Cited by 312
Resting State Networks and Consciousness
Heine, L., Soddu, A., Gómez, F., Vanhaudenhuyse, A., Tshibanda, L., Thonnard, M., Charland-Verville, V., Kirsch, M., Laureys, S., & Demertzi, A. (2012) · Frontiers in Psychology · doi:10.3389/fpsyg.2012.00295 · Cited by 272
Deconstruction for Reconstruction: The Role of Proteolysis in Neural Plasticity and Disease
Bingol, B., & Sheng, M. (2011) · Neuron · doi:10.1016/j.neuron.2010.11.006 · Cited by 275
Amyloid-β as a Modulator of Synaptic Plasticity
Parihar, M. S., & Brewer, G. J. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101020 · Cited by 247
“Later studies confirmed the activation of the PKA/CREB pathway in both cultured neurons and murine hippocampal slices after inhibition of LTP by A β [204,205].”
Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease
García-Osta, A., Cuadrado-Tejedor, M., García-Barroso, C., Oyarzábal, J., & Franco, R. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn3000907 · Cited by 259
d-serine levels in Alzheimer’s disease: implications for novel biomarker development
Madeira, C., Lourenco, M. V., Vargas-Lopes, C., Suemoto, C. K., Brandão, C. O., Reis, T., Leite, R. E. P., Laks, J., Jacob-Filho, W., Pasqualucci, C. A., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.52 · Cited by 229
Ricobaraza, A., Cuadrado‐Tejedor, M., Marco, S., Pérez‐Otaño, I., & García‐Osta, A. (2012) · Hippocampus · doi:10.1002/hipo.20883 · Cited by 239
“Synapse dysfunction and loss occur in mouse models and AD subjects, and correlate well with the earliest signs of cognitive impairment (Terry et al., 1991; Jacobsen et al., 2006; Smith et al., 2009).”
BackgroundInfluentialKurup, P., Zhang, Y., Xu, J., Venkitaramani, D. V., Haroutunian, V., Greengard, P., Nairn, A. C., & Lombroso, P. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0157-10.2010 · Cited by 224
“, 2004), whereas restoring ubiquitin-recycling enzymes rescues memory deficits and dendritic spine alterations in the AD mouse models (Gong et al., 2006; Smith et al., 2009).”
BackgroundRamanan, V. K., & Saykin, A. J. (2013) · Europe PMC (PubMed Central) · Cited by 259
Goure, W. F., Krafft, G. A., Jerecic, J., & Hefti, F. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt272 · Cited by 190
“P53-Bax cell death pathway [146] cAMP/PKA/CREB-signaling pathway [147,148] Tau protein kinase 1/glycogen synthase kinase-3β [51]”
BackgroundChronic Stress Remodels Synapses in an Amygdala Circuit-Specific Manner
Zhang, J.-Y., Liu, T.-H., He, Y., Pan, H.-Q., Zhang, W.-H., Yin, X.-P., Tian, X.-L., Li, B.-M., Wang, X.-D., Holmes, A., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.06.019 · Cited by 183
“Dendritic spines were counted and categorized with the aid of ImageJ software (National Institute of Mental Health, Bethesda, MD) (27).”
MethodLacampagne, A., Liu, X., Reiken, S., Bussiere, R., Meli, A. C., Lauritzen, I., Teich, A. F., Zalk, R., Saint, N., Arancio, O., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1733-7 · Cited by 181
Self-citationTau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Bakota, L., & Brandt, R. (2016) · Drugs · doi:10.1007/s40265-015-0529-0 · Cited by 170
Kitazawa, M., Medeiros, R., & M. LaFerla, F. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799315786 · Cited by 178
Gong, B., Radulovic, M., Figueiredo-Pereira, M. E., & Cardozo, C. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00004 · Cited by 165
“This signaling pathway has been shown to be compromised by Aβ both in vitro, using oligomeric Aβ treated cultured neurons or brain slices, and in vivo as evidenced by Aβ overproducing transgenic AD mouse models (Vitolo et al., 2002; Gong et al., 2004; Smith et al., 2009).”
BackgroundSelf-citationValor, L., Viosca, J., Lopez-Atalaya, J., & Barco, A. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990382 · Cited by 172
“Rolipram treatment of neuronal cultures and hippocampal slices reverses the effects of A pathogenic peptide at the levels of CREB phosphorylation and LTP deficits [149] and dendritic spine alterations [186].”
BackgroundFitting, S., Ignatowska-Jankowska, B. M., Bull, C., Skoff, R. P., Lichtman, A. H., Wise, L. E., Fox, M. A., Su, J., Medina, A. E., Krahe, T. E., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.026 · Cited by 162
“sustained deficits in dendritic structure and function are reversible (81).”
BackgroundGSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression
Pláteník, J., Fišar, Z., Buchal, R., Jirák, R., Kitzlerová, E., Zvěřová, M., & Raboch, J. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.12.001 · Cited by 161
“The principal neuropathological features of AD include formation of senile plaques, which are composed of amyloid-β (Aβ) oligomers, and intracellular neurofibrillary tangles, which are composed of hyperphosphorylated tau protein.”
BackgroundMulti-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model
Fang, F., Chen, X., Huang, T., Lue, L.-F., Luddy, J. S., & Yan, S. S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.004 · Cited by 160
“Acute alterations in dendritic spines induced by Aβ as well as chronic loss of spine density seen in mAPP transgenic mice are both reversible by treatments that restore the cAMP/PKA/CREB signaling pathway [49].”
Schonberg, T., Fox, C. R., Mumford, J. A., Congdon, E., Trepel, C., & Poldrack, R. A. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00080 · Cited by 162
Synaptic Therapy in Alzheimer's Disease: A CREB-centric Approach
Teich, A. F., Nicholls, R. E., Puzzo, D., Fiorito, J., Purgatorio, R., Fà, M., & Arancio, O. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0327-5 · Cited by 168
“Additional work has also shown that Uch-L1 treatment can restore spine density in mouse models of AD, and this effect is seen even in elderly mice [38].”
Self-citationKelly, M. P. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.11.004 · Cited by 161
Insulin‐like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice
Pascual‐Lucas, M., Viana da Silva, S., Di Scala, M., Garcia‐Barroso, C., González‐Aseguinolaza, G., Mulle, C., Alberini, C. M., Cuadrado‐Tejedor, M., & Garcia‐Osta, A. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404228 · Cited by 145
“Furthermore, the formation and maturation of synapses in the hippocampus, a mechanism that is impaired in AD (Jacobsen et al , 2006; Smith et al , 2009; Ricobaraza et al , 2012) and depends on IGF2/IGF2R signalling, may underlie the IGF2-dependent memory enhancement effect (Schmeisser et al , 2012).”
Espana, J., Valero, J., Minano-Molina, A. J., Masgrau, R., Martin, E., Guardia-Laguarta, C., Lleo, A., Gimenez-Llort, L., Rodriguez-Alvarez, J., & Saura, C. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2154-10.2010 · Cited by 127
“Interestingly, altered cAMP/PKA-dependent CREB signaling has been postulated to mediate the effect of A on hippocampal synaptic plasticity, memory, and synapse loss (Vitolo et al., 2002; Gong et al., 2006; Smith et al., 2009).”
BackgroundPilakka-Kanthikeel, S., Atluri, V. S. R., Sagar, V., Saxena, S. K., & Nair, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062241 · Cited by 135
Sierksma, A. S. R., van den Hove, D., Pfau, F., Philippens, M., Bruno, O., Fedele, E., Ricciarelli, R., Steinbusch, H. W. M., Vanmierlo, T., & Prickaerts, J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.015 · Cited by 139
“Additionally, 3-week rolipram administration could ameliorate AD-related alterations in dendrite and spine morphology in a mouse model of AD (Smith et al., 2009).”
BackgroundGuo, H., Cheng, Y., Wang, C., Wu, J., Zou, Z., Niu, B., Yu, H. M., Wang, H., & Xu, J. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.004 · Cited by 137
“Interestingly, PDE4 inhibitors appear to exert beneficial effects without affecting the Ab level or amyloid plaques (Gong et al., 2004; Sierksma et al., 2014; Smith et al., 2009).”
Spines, plasticity, and cognition in Alzheimer's model mice
Spires-Jones, T., & Knafo, S. (2012) · Neural Plasticity · doi:10.1155/2012/319836 · Cited by 133
“Indeed, evidence of functional compensation in response to spine loss induced by Aβ has been observed in several models [87–89].”
ResultKurapati, K. R. V., Atluri, V. S. R., Samikkannu, T., & Nair, M. P. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077624 · Cited by 129
“Altered cellular morphology and architecture in β-amyloid (Figure 6B) as well as β-amyloid plus ashwagandha (Figure 6D) and control (Figure 6A) and only ashwagandha (Figure 6C) treated SK-N-MC cells were captured using confocal microscopy and morphological changes were analyzed using the established protocol [35].”
MethodNovel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer’s Disease: Miniperspective
Wu, Y., Li, Z., Huang, Y.-Y., Wu, D., & Luo, H.-B. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01370 · Cited by 122
Corsetti, V., Florenzano, F., Atlante, A., Bobba, A., Ciotti, M. T., Natale, F., Della Valle, F., Borreca, A., Manca, A., Meli, G., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv059 · Cited by 129
Tundo, G. R., Sbardella, D., Santoro, A. M., Coletta, A., Oddone, F., Grasso, G., Milardi, D., Lacal, P. M., Marini, S., Purrello, R., et al. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107579 · Cited by 126
Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease
Penzes, P., & VanLeeuwen, J.-E. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2011.01.003 · Cited by 114
Phosphodiesterase-4 (PDE4) Molecular Pharmacology and Alzheimer's Disease
Gurney, M. E., D'Amato, E. C., & Burgin, A. B. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0309-7 · Cited by 121
Glutamatergic synaptic plasticity and dysfunction in Alzheimer disease: Emerging mechanisms
Benarroch, E. E. (2018) · Neurology · doi:10.1212/wnl.0000000000005807 · Cited by 115
“Loss of dendritic spines occurs early during AD and is potentially reversible.(92) So far, the only potentially neuroprotective approach has been the use of memantine, based on its weak inhibitory effects on extrasynaptic NMDARs(93); however,memantine also has inhibitory effects on synaptic NMDARs.”
BackgroundThe dendritic hypothesis for Alzheimer's disease pathophysiology
Cochran, J. N., Hall, A. M., & Roberson, E. D. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.12.004 · Cited by 114
“As with neuritic dystrophy, spine loss is also reversible in an animal model of AD [176].”
BackgroundCrtc1 Activates a Transcriptional Program Deregulated at Early Alzheimer's Disease-Related Stages
Parra-Damas, A., Valero, J., Chen, M., España, J., Martín, E., Ferrer, I., Rodríguez-Alvarez, J., & Saura, C. A. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.5288-13.2014 · Cited by 101
“Previous studies showed that pharmacological and genetic activation of CREB signaling ameliorate synaptic and memory deficits in AD transgenic mice (Vitolo et al., 2002; Gong et al., 2004; Smith et al., 2009; Caccamo et al., 2010; Yiu et al., 2011).”
BackgroundLuebke, J. I., Weaver, C. M., Rocher, A. B., Rodriguez, A., Crimins, J. L., Dickstein, D. L., Wearne, S. L., & Hof, P. R. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0244-2 · Cited by 109
“For example, recent studies have demonstrated reversal of dendritic pathology in APP/PS1 mutant mice upon treatment with both rolipram and TAT-HA-Uch-L1 (Smith et al. 2009) or with Ab immunotherapy in Tg2576 and APP/PS1 mice (Lombardo et al. 2003; Biscaro et al. 2009; Rozkalne et al. 2009).”
Protein Phosphatases and Alzheimer's Disease
Braithwaite, S. P., Stock, J. B., Lombroso, P. J., & Nairn, A. C. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-396456-4.00012-2 · Cited by 107
“Notably, proteasome activity decreases with age in the brains of Tg2576 mice,(226) while restoring ubiquitin-recycling enzymes rescues memory deficits and dendritic spine alterations in AD mouse models.(224,227) STEP degradation is controlled by the UPS, and impairment of the UPS seen in response to Ab in cell-based a…”
Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders
Bhat, A., Ray, B., Mahalakshmi, A. M., Tuladhar, S., Nandakumar, D., Srinivasan, M., Essa, M. M., Chidambaram, S. B., Guillemin, G. J., & Sakharkar, M. K. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105078 · Cited by 113
Wiley, J. C., Pettan-Brewer, C., & Ladiges, W. C. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00680.x · Cited by 103
“One of the primary deficits associated with both AD transgenic mice and patients with AD is the loss of synapses in the pathogenically affected regions of the brain (Grutzendler et al., 2007; Lacor et al., 2007; Spires-Jones et al., 2007; Smith et al., 2009).”
BackgroundLjungberg, M. C., Ali, Y. O., Zhu, J., Wu, C.-S., Oka, K., Zhai, R. G., & Lu, H.-C. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr492 · Cited by 107
“Defective CREB signaling has been postulated to mediate the effect of Ab on hippocampal function (46,51,71,72) and pCREB levels are also reduced in 3xTg mice at 6 months of age (48).”
BackgroundIs the Amyloid Hypothesis of Alzheimer's disease therapeutically relevant?
Teich, A. F., & Arancio, O. (2012) · Biochemical Journal · doi:10.1042/bj20120653 · Cited by 102
Self-citationRetinal ganglion cell dendritic degeneration in a mouse model of Alzheimer's disease
Williams, P. A., Thirgood, R. A., Oliphant, H., Frizzati, A., Littlewood, E., Votruba, M., Good, M. A., Williams, J. H., & Morgan, J. E. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.01.006 · Cited by 112
Protein Homeostasis, Aging and Alzheimer’s Disease
Morawe, T., Hiebel, C., Kern, A., & Behl, C. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8246-0 · Cited by 107
“Interestingly, when overexpressed, UCH-L1 reverses behavioral deficits in AD model mice consistent with an impairment of the UPS in AD [124, 125].”
BackgroundCheng, Y., Wang, C., Lin, H.-B., Li, Y., Huang, Y., Xu, J., & Zhang, H. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1943-3 · Cited by 111
Yiu, A. P., Rashid, A. J., & Josselyn, S. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.107 · Cited by 105
Role of ubiquitin–proteasome-mediated proteolysis in nervous system disease
Hegde, A. N., & Upadhya, S. C. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.07.006 · Cited by 96
Protection of primary neurons and mouse brain from Alzheimer's pathology by molecular tweezers
Attar, A., Ripoli, C., Riccardi, E., Maiti, P., Li Puma, D. D., Liu, T., Hayes, J., Jones, M. R., Lichti-Kaiser, K., Yang, F., et al. (2012) · Brain · doi:10.1093/brain/aws289 · Cited by 93
Zhang, M., Zheng, C.-Y., Zou, M., Zhu, J.-W., Zhang, Y., Wang, J., Liu, C., Li, Q., Xiao, Z., Li, S., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.06.009 · Cited by 97
Psychological co-morbidities in COPD: Targeting systemic inflammation, a benefit for both?
Pelgrim, C. E., Peterson, J. D., Gosker, H. R., Schols, A. M. W. J., van Helvoort, A., Garssen, J., Folkerts, G., & Kraneveld, A. D. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.10.001 · Cited by 90
Locus coeruleus, norepinephrine and Aβ peptides in Alzheimer's disease
Ross, J. A., McGonigle, P., & Van Bockstaele, E. J. (2015) · Neurobiology of Stress · doi:10.1016/j.ynstr.2015.09.002 · Cited by 84
Cyclophilin D deficiency rescues Aβ-impaired PKA/CREB signaling and alleviates synaptic degeneration
Du, H., Guo, L., Wu, X., Sosunov, A. A., McKhann, G. M., Chen, J. X., & Yan, S. S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.004 · Cited by 85
“PKA/CREB signaling cascade is affected in Aβ-rich environment leading to dendritic spine architecture change in an AD mouse model [32], suggesting the deleterious role of PKA/CREB disturbances in synaptic alteration in AD.”
BackgroundSierksma, A. S. R., Rutten, K., Sydlik, S., Rostamian, S., Steinbusch, H. W. M., van den Hove, D., & Prickaerts, J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.048 · Cited by 92
Gong, B., Chen, F., Pan, Y., Arrieta‐Cruz, I., Yoshida, Y., Haroutunian, V., & Pasinetti, G. M. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00632.x · Cited by 82
“Previously, our group reported that the cAMP-PKApCREB signaling pathway is downregulated in the AD brain and that augmenting this pathway by increasing PKA activity improves the deficits of synaptic function in an AD mouse model (Gong et al., 2004, 2006; Smith et al., 2009).”
BackgroundSelf-citationSpecific Inhibition of Phosphodiesterase-4B Results in Anxiolysis and Facilitates Memory Acquisition
McGirr, A., Lipina, T. V., Mun, H.-S., Georgiou, J., Al-Amri, A. H., Ng, E., Zhai, D., Elliott, C., Cameron, R. T., Mullins, J. G. L., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.240 · Cited by 86
Methods of dendritic spine detection: From Golgi to high-resolution optical imaging
Mancuso, J. J., Chen, Y., Li, X., Xue, Z., & Wong, S. T. C. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.010 · Cited by 92
“Strikingly, treatments that alleviate the cognitive symptoms of neurodegenerative disease also have been shown to reverse their respective spine pathologies (Smith et al., 2009).”
BackgroundMicrotubule dynamics and the neurodegenerative triad of Alzheimer's disease: The hidden connection
Brandt, R., & Bakota, L. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14011 · Cited by 80
Cao, J., Zhong, M. B., Toro, C. A., Zhang, L., & Cai, D. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.03.016 · Cited by 79
The Ubiquitin System in Alzheimer’s Disease
Harris, L. D., Jasem, S., & Licchesi, J. D. F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_8 · Cited by 85
The Effect of Parkinson's-Disease-Associated Mutations on the Deubiquitinating Enzyme UCH-L1
Andersson, F. I., Werrell, E. F., McMorran, L. M., Crone, W. J. K., Das, C., Hsu, S. D., & Jackson, S. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.12.029 · Cited by 88
“Recently, UCH-L1 has been shown to restore dendritic spine density in hAPP transgenic mice, which show acute alterations to dendritic spines induced by Aβ.(12) In addition to their possible role with Aβ, two mutations that have been associated with a decreased susceptibility to Parkinson's disease (PD) (S18Y) or with…”
Inhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL/6J mice
Blednov, Y. A., Benavidez, J. M., Black, M., & Harris, R. A. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00129 · Cited by 74
“ORIGINAL RESEARCH ARTICLE published: 27 May 2014 doi: 10.3389/fnins.2014.00129 Inhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL/6J mice”
BackgroundInfluentialGurney, M. E., Nugent, R. A., Mo, X., Sindac, J. A., Hagen, T. J., Fox, D. N. A., O’Donnell, J. M., Zhang, C., Xu, Y., Zhang, H., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00193 · Cited by 80
McIntire, L. B. J., Berman, D. E., Myaeng, J., Staniszewski, A., Arancio, O., Di Paolo, G., & Kim, T.-W. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2034-12.2012 · Cited by 74
“Cultures were exposed to 200nM A β oligomer for 24 hours, fixed with 4% paraformaldehyde and DiOlistically labeled with Dil (Molecular Probes, Smith et al., 2009).”
Self-citationZhang, C., Xu, Y., Chowdhary, A., Fox, D. N. A., Gurney, M. E., Zhang, H., Auerbach, B. D., Salvi, R., Yang, M., Li, G., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0178-6 · Cited by 83
Wang, S., Yu, L., Yang, H., Li, C., Hui, Z., Xu, Y., & Zhu, X. (2016) · PLOS ONE · doi:10.1371/journal.pone.0151397 · Cited by 69
“The development of dendrites and the number of dendritic spines, which are compromised in AD mice, can both affect synaptic function[30].”
BackgroundFeng, H., Wang, C., He, W., Wu, X.-J., Li, S., Zeng, Z., Wei, M., & He, B. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-018-0374-4 · Cited by 72
Bartolotti, N., & Lazarov, O. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.01.004 · Cited by 74
Inhibition of NMDA Receptors Prevents the Loss of BDNF Function Induced by Amyloid β
Tanqueiro, S. R., Ramalho, R. M., Rodrigues, T. M., Lopes, L. V., Sebastião, A. M., & Diógenes, M. J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00237 · Cited by 66
The visinin-like proteins VILIP-1 and VILIP-3 in Alzheimer’s disease—old wine in new bottles
Braunewell, K. H. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00020 · Cited by 66
“…proteins in subpopulations of hippocampal interneurons, may render these neurons particularly vulnerable against Aβ-induced morphological disturbances, such as reduced dendritic spinogenesis in AD, which are significantly contributing to cognitive decline (Smith et al., 2009; Wei et al., 2010).”
BackgroundInfluentialGene expression parallels synaptic excitability and plasticity changes in Alzheimer’s disease
Saura, C. A., Parra-Damas, A., & Enriquez-Barreto, L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00318 · Cited by 65
“Accordingly, CREB activation ameliorates synaptic and memory deficits in APP transgenic mice (Smith et al., 2009; Yiu et al., 2011), whereas CRTC1 gene therapy reverses early transcriptional changes and memory impairments in AD mice (Parra-Damas et al., 2014).”
BackgroundLong, Z., Zhao, L., Jiang, R., Wang, K., Luo, S., Zheng, M., Li, X., & He, G. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12445 · Cited by 67
“It is characterized by progressive cognitive deficits, memory impairment, and behavioral changes [1].”
BackgroundLee, C., Chang, C., Lin, C., Lai, H., Kao, Y.-H., Cheng, S., Chen, H., Liao, Y., Faivre, É., Buée, L., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1030-z · Cited by 66
Dong, H., Murphy, K. M., Meng, L., Montalvo-Ortiz, J., Zeng, Z., Kolber, B. J., Zhang, S., Muglia, L. J., & Csernansky, J. G. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-111328 · Cited by 60
“Spine loss and regression have been reported in human studies in the context of normal aging [57] and neurodegenerative disorders, including AD [58, 59].”
Bonardi, C., de Pulford, F., Jennings, D. J., & Pardon, M. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.03.041 · Cited by 74
Fluorescent labeling of dendritic spines in cell cultures with the carbocyanine dye “DiI”
Cheng, C., Trzcinski, O., & Doering, L. C. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00030 · Cited by 67
Wolf, C., & Linden, D. E. J. (2012) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2011.00752.x · Cited by 56
Isoflurane Reversibly Destabilizes Hippocampal Dendritic Spines by an Actin-Dependent Mechanism
Platholi, J., Herold, K. F., Hemmings, H. C., & Halpain, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102978 · Cited by 60
Synaptic Compensatory Plasticity in Alzheimer’s Disease
Bhembre, N., Bonthron, C., & Opazo, P. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0379-23.2023 · Cited by 59
del Valle, J., Bayod, S., Camins, A., Beas-Zárate, C., Velázquez-Zamora, D. A., González-Burgos, I., & Pallàs, M. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-120718 · Cited by 53
“As synapse loss is strongly correlated with cognitive impairment in AD [25], synaptic damage and loss are factors that affect the degree of dementia experienced in AD patients [26].”
BackgroundLaguesse, S., Morisot, N., Shin, J. H., Liu, F., Adrover, M. F., Sakhai, S. A., Lopez, M. F., Phamluong, K., Griffin, W. C., Becker, H. C., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.08.037 · Cited by 57
Atluri, V. S. R., Pilakka‐Kanthikeel, S., Reddy, P. V. B., Yndart, A., & Nair, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061399 · Cited by 59
A loss of FUS/TLS function leads to impaired cellular proliferation
Ward, C. L., Boggio, K. J., Johnson, B. N., Boyd, J. D., Douthwright, S., Shaffer, S. A., Landers, J. E., Glicksman, M. A., & Bosco, D. A. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.508 · Cited by 64
Multisite Organic–Inorganic Hybrid Catalysts for the Direct Sustainable Synthesis of GABAergic Drugs
Leyva‐Pérez, A., García, P. G., & Corma, A. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403049 · Cited by 55
Targeting the 26S Proteasome To Protect Against Proteotoxic Diseases
Myeku, N., & Duff, K. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.11.006 · Cited by 61
“The first study to show the effect of PDE inhibition on UPS-mediated degradation of diseaserelated proteins [62,63] demonstrated that administration of either rolipram (a selective PDE4 inhibitor) or purified cell-permeable Uch-L1 (ubiquitin C-terminal hydrolase L1) led to proteasome-mediated degradation in a mouse mo…”
Wang, Z.-Z., Yang, W.-X., Zhang, Y., Zhao, N., Zhang, Y.-Z., Liu, Y.-Q., Xu, Y., Wilson, S. P., O'Donnell, J. M., Zhang, H.-T., et al. (2015) · Scientific Reports · doi:10.1038/srep11332 · Cited by 51
“8 mA, 5-s duration, 60-s inter-shock interval); (6) white noise (110 dB); (7) tail pinch (1 cm apart from the end of the tail); (8) damp sawdust (200 ml water absorbed in sawdust bedding); (9) sawdust-free cage; (10) sawdust-free cage with 200 ml water (21 °C); (11) continuous cage shaking (high speed horizontal shaki…”
BackgroundWang, Z., Zhang, Y., Liu, Y., Zhao, N., Zhang, Y., Li, Y., An, L., Li, J., Wang, X., Qin, J., et al. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02225.x · Cited by 59
“…and brain-derived neurotrophic factor (BDNF) (Fujimaki et al., 2000; Itoh et al., 2004), and subsequently improves neuroplasticity (Fujioka et al., 2004; Smith et al., 2009), the neurobiological basis of antidepressant activity (Manji et al., 2001) and memory enhancement (Dumitriu et al., 2010).”
BackgroundNaskar, A., Manivasagam, T., Chakraborty, J., Singh, R. P., Thomas, B., Dhanasekaran, M., & Mohanakumar, K. P. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12076 · Cited by 56
“For counting the dendritic spines and morphometric analysis, Image J software was used [34].”
MethodBączyńska, E., Pels, K. K., Basu, S., Włodarczyk, J., & Ruszczycki, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084053 · Cited by 49
“Smith et al. 2009 PNAS [35] Acute hippocampal slices, fixed DiI staining, DiOlistic method Confocal microscope Spine density, area, length, head diameter Min.”
MethodEftekharzadeh, B., Ramin, M., Khodagholi, F., Moradi, S., Tabrizian, K., Sharif, R., Azami, K., Beyer, C., & Sharifzadeh, M. S. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.08.015 · Cited by 50
Messing, L., Decker, J. M., Joseph, M., Mandelkow, E., & Mandelkow, E.-M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.024 · Cited by 48
“The hippocampus is highly affected in AD (Braak and Braak, 1991; Smith et al., 2009).”
BackgroundKasza, Á., Hunya, Á. G., Frank, Z., Fülöp, F., Török, Z., Balogh, G. E., Sántha, M., Bálind, Á., Bernáth, S., Blundell, K. L. I. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150860 · Cited by 46
“According to the literature, APPxPS1 mice undergo spine loss already by the age of 4 months [79].”
Background
Metadata
- Authors
- Smith, D. L., Pozueta, J., Gong, B., Arancio, O., & Shelanski, M.
- Affiliations
- Columbia University (US)
- Guy's Hospital (GB)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-09-29
- Volume
- 106
- Issue
- 39
- Pages
- 16877-16882
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2743726
- OpenAlex
- W1977390447
- Cited by
- 229
- References
- 42
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 7 · 2023: 9 · 2022: 6 · 2021: 7 · 2020: 21 · 2019: 10 · 2018: 16 · 2017: 20 · 2016: 10 · 2015: 17 · 2014: 22 · 2013: 18 · 2012: 23
- FWCI
- 12.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (AG 008700)
- National Institute of Neurological Disorders and Stroke (NS15076, R01NS015076)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, dendritic spines, synaptic loss, amyloid-beta, APP transgenic mice, rolipram, cAMP/PKA/CREB signaling, proteasome function, UCHL1, dystrophic neurites, hippocampus, cognitive impairment
- MeSH terms
- Alzheimer Disease, Animals, Brain, Dendrites, Disease Models, Animal, Hippocampus, Humans, Mice, Transgenic, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Dendritic Spines, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.